𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P.1.030 Double-blind, placebo-controlled,multicenter study evaluating nemifitide, a new pentapeptide antidepressant, when given daily or every other day for three weeks in the treatment of major depressive disorder

✍ Scribed by J.P. Feighner; L. Sverdlov; J. Hlavka; G. Nicolau; G. Tonelli; J. Freed


Book ID
118591241
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
101 KB
Volume
15
Category
Article
ISSN
0924-977X

No coin nor oath required. For personal study only.